Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity.

Saved in:
Bibliographic Details
Title: Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity.
Authors: Ho TM; Department of Chemistry, The University of Texas at San Antonio San Antonio TX 78249 USA francis.yoshimoto@gmail.com., Yoshimoto FK; Department of Chemistry, The University of Texas at San Antonio San Antonio TX 78249 USA francis.yoshimoto@gmail.com.
Source: RSC medicinal chemistry [RSC Med Chem] 2025 Dec 29. Date of Electronic Publication: 2025 Dec 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem
Database: MEDLINE Ultimate
Description
ISSN:2632-8682
DOI:10.1039/d5md00954e